Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 92 | ETA2023 | Next issue

45th Annual Meeting of the European Thyroid Association (ETA) 2023

45th Annual Meeting of the European Thyroid Association ETA 2023

Oral Session 4: Young Investigators / Clinical and Translational

ea0092op-04-01 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Interaction between DIO2 polymorphisms and LT4 treatment on psychological well-being outcomes and cardiovascular risk factors: a population-based cross-sectional study in uk biobank

Zinck Jensen Christian , Lynggaard Isaksen Jonas , Ahlberg Gustav , Salling Olesen Morten , Nygaard Birte , Ellervik Christina , Kim Kanters Jorgen

Objectives: Some evidence suggests gene-treatment interactions might cause persistent symptoms in individuals receiving levothyroxine (LT4) treatment. We investigated, as previously hypothesized, if single nucleotide polymorphisms (SNPs) in rs225014 (Thr92Ala), rs225015, or rs12885300 (ORFa-Gly3Asp) in the Deiodinase 2 gene (DIO2), or rs17606253 in the Monocarboxylate Transporter 10 gene (MCT10) were associated with outcomes indicative of local tissue hypothyroidism in LT4-tre...

ea0092op-04-02 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Teprotumumab-Related adverse events in thyroid eye disease: a multi-center real world study

Shah Shreya , Amarikwa Linus , Sears Connie , Ugradar Shoaib , Clauss Kevin , Rajjoub Raneem , Kang Julia , Tamhankar Madhura , Briceno Cesar , Harrison Andrew , Dosiou Chrysoula , Cockerham Kimberly , Wester Sara , Douglas Raymond , Kossler Andrea

Objectives: The insulin-like growth factor I receptor (IGF-1R) plays a significant role in the pathology of thyroid eye disease (TED), an autoimmune disorder characterized by orbital inflammation. Teprotumumab, a human monoclonal antibody targeting IGF-1R, has demonstrated efficacy in treating moderate-to-severe TED. A significant proportion of patients experienced adverse events (AEs), with 74% and 85% reporting an AE and 12% and 5% reporting serious AEs in Phase 2 and 3 tria...

ea0092op-04-03 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Long-Term outcome of the thyroid function in graves’ disease: a nationwide danish register study

Sophia Eriksen Anine , Folkestad Lars , Brix Thomas , Joop Bonnema Steen

Background: Little is known about the long-term outcome of the thyroid function in Graves’ disease in a large epidemiological setting.Objective: The aim was to evaluate the long-term outcome of the thyroid function in patients diagnosed with Graves’ disease in Denmark in the period 1995-2018. Our research objectives were to investigate the incidence of disease, use of antithyroid drugs, radioactive iodine, thyroidectomy and levothyroxine during...

ea0092op-04-04 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

The association between maternal thyroid function and language acquisition in offspring aged 12 to 37 months: an odense child cohort study

Ryom Riis Kamilla , Joop Bonnema Steen , Fenger Dreyer Anja , Kold Jensen Tina , Glintborg Dorte , Bilenberg Niels , Bleses Dorthe , Trecca Fabio , Andersen Marianne

Introduction: Maternal thyroid function in early pregnancy is crucial for fetal neural development. Early offspring language acquisition is an important indicator of fetal neural development and a predictor of future cognitive development. We aimed to investigate how the mother’s thyroid function and the presence of thyroid autoimmunity in early pregnancy are associated with offspring’s language acquisition at the age of 12-37 months.Methods: T...

ea0092op-04-05 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Active surveillance: a feasible option for indeterminate thyroid nodules

Ghirri Arianna , Prete Alessandro , Ramone Teresa , Romei Cristina , Rago Teresa , Elisei Rossella , Molinaro Eleonora

Introduction: The surgical approach is the first line treatment for patients with an indeterminate nodule, both without and with nuclear atypia (TIR3A and TIR3B, respectively, as defined by Italian Consensus for thyroid cytology). However, there are no prospective studies about the feasibility of active surveillance in patients with indeterminate thyroid nodules.Methods: Eighty-six consecutive patients who decided to undergo active surveillance for at le...

ea0092op-04-06 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Cardiac function during early treatment for differentiated thyroid carcinoma

Links Mirthe , Lefrandt Joop , Van Der Boom Trynke , Willems Tineke , van der Meer Peter , Links Thera , Zandee Wouter

Background: Differentiated thyroid carcinoma (DTC) survivors have an increased risk of cardiovascular mortality but, the pathophysiological mechanism remains largely unknown. Early treatment for high-risk DTC entails thyroid surgery, radioiodine therapy with thyroid hormone (TH)-withdrawal, and thyroxine suppression therapy (THST). During treatment, patients cycle from severe hypothyroidism to exogenous subclinical hyperthyroidism. TH changes in early DTC treatment might affec...